Search for Clinical Trial Results
Coinfection - 25 Studies Found
Status | Study |
Completed |
Study Name: Effects of Viral and Bacterial Co-infections in Otherwise Healthy Children Hospitalized in Pediatric Department Condition: Coinfection Date: 2014-12-02 Interventions: Other: No intervention As this is an observational study, no intervention was conducted. |
Completed |
Study Name: A Pilot Study To Evaluate the Efficacy of Response Guided Therapy of Peginterferon Alfa Plus Ribavirin in the Treatment of Patients With HCV/HBV Co-Infection Condition: HBV/HCV Co-infection Date: 2015-01-12 Interventions: Other: Abbreviation of treatment duration |
Terminated |
Study Name: Pegasys Long-Term Anti-Fibrotic Effect Co-Infection Trial (PERFECT) Condition: HIV/HCV Coinfection Date: 2016-05-03 Interventions: Drug: Peginterferon Alfa-2 Peginterferon alfa-2a will be administered as 90 micrograms (mcg) via subcuta |
Completed |
Study Name: Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection Condition: Hepatitis C Infection With HIV Co-Infection Date: 2015-05-27 Interventions: Drug: LDV/SOF 90/400 mg FDC tablet administered orally once daily |
Completed |
Study Name: Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection Condition:
|
Completed |
Study Name: Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r Condition:
Date: 2009-03-18 Interventions:
|
Completed |
Study Name: Tenofovir in HIV/HBV Coinfection Condition:
Date: 2005-09-11 Interventions:
|
Completed |
Study Name: HIV-HBV Co-Infection and Liver Disease Condition:
Date: 2008-03-11 |
Completed |
Study Name: Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders Condition: HCV-HIV Co-Infection Date: 2012-10-22 Interventions: Drug: Asunaprevir, Daclatasvir, Ribavirin and Peginterferon alfa-2a |
Completed |
Study Name: Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection Condition:
|